Literature DB >> 21982484

Interaction of folate intake and the paraoxonase Q192R polymorphism with risk of incident coronary heart disease and ischemic stroke: the atherosclerosis risk in communities study.

Hung N Luu1, Pascal L Kingah, Kari North, Eric Boerwinkle, Kelly A Volcik.   

Abstract

PURPOSE: To investigate the potential interaction between folate intake and the paraoxonase 1 (PON1) Q192R polymorphism with the risk of incident coronary heart disease (CHD) and ischemic stroke in the Atherosclerosis Risk in Communities study, a population-based prospective cohort of cardiovascular disease in 15,792 white and African-American subject.
METHODS: Race-stratified Cox proportional hazards models were performed to examine the interaction between folate intake and the PON1 Q192R polymorphism.
RESULTS: A significant inverse association between folate intake and risk of incident CHD among white subjects was found (hazard rate ratio, 1.30; 95% confidence interval, 1.09-1.56; P = .004; folate intake ≤155 μg vs ≥279 μg, reference group). An interaction effect was observed between the dominant genetic model and folate intake with regards to incident ischemic stroke in white subjects (hazard rate ratio, 0.68; 95% confidence interval, 0.91-0.99; and 1.24 from 1st-4th quartile, respectively; P-trend = .05).
CONCLUSIONS: There was an interaction between folate intake and PON1 Q192 polymorphism with regard to the risk of ischemic stroke in white subjects. Future studies should investigate the interaction between additional polymorphisms within the PON1 gene and genetic variants in other folate metabolizing genes with folate intake on the risk of incident CHD and stroke.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21982484      PMCID: PMC3190162          DOI: 10.1016/j.annepidem.2011.08.007

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  49 in total

1.  Low dietary folate intake is associated with an excess incidence of acute coronary events: The Kuopio Ischemic Heart Disease Risk Factor Study.

Authors:  S Voutilainen; T H Rissanen; J Virtanen; T A Lakka; J T Salonen
Journal:  Circulation       Date:  2001-06-05       Impact factor: 29.690

2.  Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype?

Authors:  B Mackness; G K Davies; W Turkie; E Lee; D H Roberts; E Hill; C Roberts; P N Durrington; M I Mackness
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-09       Impact factor: 8.311

3.  Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study. National Health and Nutrition Examination Survey.

Authors:  Lydia A Bazzano; Jiang He; Lorraine G Ogden; Catherine Loria; Suma Vupputuri; Leann Myers; Paul K Whelton
Journal:  Stroke       Date:  2002-05       Impact factor: 7.914

4.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

Authors: 
Journal:  JAMA       Date:  2002 Oct 23-30       Impact factor: 56.272

5.  Genetic determinants of homocysteine thiolactonase activity in humans: implications for atherosclerosis.

Authors:  H Jakubowski; W T Ambrosius; J H Pratt
Journal:  FEBS Lett       Date:  2001-02-23       Impact factor: 4.124

Review 6.  Folates and cardiovascular disease.

Authors:  M C Verhaar; E Stroes; T J Rabelink
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-01       Impact factor: 8.311

Review 7.  The controversy over homocysteine and cardiovascular risk.

Authors:  P M Ueland; H Refsum; S A Beresford; S E Vollset
Journal:  Am J Clin Nutr       Date:  2000-08       Impact factor: 7.045

8.  Evidence for association between paraoxonase gene polymorphisms and atherosclerotic diseases.

Authors:  Y Imai; H Morita; H Kurihara; T Sugiyama; N Kato; A Ebihara; C Hamada; Y Kurihara; T Shindo; Y Oh-hashi; Y Yazaki
Journal:  Atherosclerosis       Date:  2000-04       Impact factor: 5.162

Review 9.  Paraoxonase and coronary heart disease.

Authors:  Michael I Mackness; Bharti Mackness; Paul N Durrington
Journal:  Atheroscler Suppl       Date:  2002-12       Impact factor: 3.235

10.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.

Authors:  David S Wald; Malcolm Law; Joan K Morris
Journal:  BMJ       Date:  2002-11-23
View more
  11 in total

1.  PON1 L55M and Q192R gene polymorphisms and CAD risks in patients with hyperlipidemia : Clinical study of possible associations.

Authors:  H Chen; S Ding; M Zhou; X Wu; X Liu; J Liu; Y Wu; D Liu
Journal:  Herz       Date:  2017-08-23       Impact factor: 1.443

2.  The Q192R polymorphism of the paraoxonase 1 gene is a risk factor for coronary artery disease in Saudi subjects.

Authors:  Mohammed A Hassan; Omar S Al-Attas; Tajamul Hussain; Nasser M Al-Daghri; Majed S Alokail; Abdul K Mohammed; Benjamin Vinodson
Journal:  Mol Cell Biochem       Date:  2013-04-27       Impact factor: 3.396

3.  Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia.

Authors:  Jonathan M Flanagan; Vivien Sheehan; Heidi Linder; Thad A Howard; Yong-Dong Wang; Carolyn C Hoppe; Banu Aygun; Robert J Adams; Geoffrey A Neale; Russell E Ware
Journal:  Blood       Date:  2013-02-19       Impact factor: 22.113

4.  Paraoxonase-1 gene Q192R and L55M polymorphisms and risk of cardiovascular disease in Egyptian patients with type 2 diabetes mellitus.

Authors:  Dalia El-Lebedy; Mona Kafoury; Dalia Abd-El Haleem; Alshaymaa Ibrahim; Eman Awadallah; Ingy Ashmawy
Journal:  J Diabetes Metab Disord       Date:  2014-12-20

5.  Paraoxonase1 genetic polymorphisms in a mixed ancestry African population.

Authors:  M Macharia; A P Kengne; D M Blackhurst; R T Erasmus; T E Matsha
Journal:  Mediators Inflamm       Date:  2014-11-16       Impact factor: 4.711

Review 6.  Effects of paraoxonase 1 gene polymorphisms on heart diseases: Systematic review and meta-analysis of 64 case-control studies.

Authors:  Yazmín Hernández-Díaz; Carlos Alfonso Tovilla-Zárate; Isela Esther Juárez-Rojop; Thelma Beatriz González-Castro; Candelario Rodríguez-Pérez; María Lilia López-Narváez; José Manuel Rodríguez-Pérez; José Francisco Cámara-Álvarez
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

7.  Dietary Intake of Homocysteine Metabolism-Related B-Vitamins and the Risk of Stroke: A Dose-Response Meta-Analysis of Prospective Studies.

Authors:  Liyun Chen; Qianwen Li; Xuexian Fang; Xinhui Wang; Junxia Min; Fudi Wang
Journal:  Adv Nutr       Date:  2020-11-16       Impact factor: 8.701

8.  Proteomics-Based Approach to Identify Novel Blood Biomarker Candidates for Differentiating Intracerebral Hemorrhage From Ischemic Stroke-A Pilot Study.

Authors:  David Malicek; Ilka Wittig; Sebastian Luger; Christian Foerch
Journal:  Front Neurol       Date:  2021-12-17       Impact factor: 4.003

Review 9.  Genomic approaches to identifying targets for treating β hemoglobinopathies.

Authors:  Duyen A Ngo; Martin H Steinberg
Journal:  BMC Med Genomics       Date:  2015-07-29       Impact factor: 3.063

10.  Joint Effects of PON1 Polymorphisms and Vegetable Intake on Ischemic Stroke: A Family-Based Case Control Study.

Authors:  Juan Juan; Xia Jiang; Xun Tang; Yiqun Wu; Kexin Sun; Xiao Xiang; Yaohua Tian; Tao Wu; Qi Sun; Peter Kraft; Yonghua Hu
Journal:  Int J Mol Sci       Date:  2017-12-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.